Sort
8,912 grants matching “sars cov 2”
Molecular mechanisms of aging and accelerated aging in the human brain
$841,971Maria Mavrikaki · Beth Israel Deaconess Medical Center · R01 · FY2023 · AG
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
$841,864Steven B Abramson · New York University School Of Medicine · R01 · FY2025 · HL
Exploring the membrane-related components of HIV-1 Env for immunogen design
$841,863Bing Chen · Boston Children'S Hospital · R01 · FY2023 · AI
The origin and future protective activity of SARS-CoV-2 RBD specific neutralizing antibodies
$841,341James J Kobie · University Of Alabama At Birmingham · R01 · FY2024 · AI
The origin and future protective activity of SARS-CoV-2 RBD specific neutralizing antibodies
$841,228James J Kobie · University Of Alabama At Birmingham · R01 · FY2022 · AI
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
$840,235Lawrence C Kleinman · Rbhs-Robert Wood Johnson Medical School · R61 · FY2021 · HD
The economic and social impact of COVID-19 mitigation policies: A cross-country analysis of macro events
$839,609Dean R Lillard · Ohio State University · R01 · FY2022 · AG
Decoding the cellular mechanisms of COVID-19 severe disease susceptibility in patients with chronic respiratory disease
$839,491Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R56 · FY2021 · HL
Early life B cell responses and inflammation following SARS-CoV-2 infection
$838,453Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)
$836,116Katharina Schultebraucks · New York University School Of Medicine · R01 · FY2023 · MH
Research Project 1 - The pregnancy ImmunOME
$835,258Andrea Goldberg Edlow · Massachusetts Institute Of Technology · U19 · FY2025 · AI
Repository of Monoclonal Antibodies (RoMA) against Hamster and Guinea Pig Proteins
$835,137Domenico Tortorella · Icahn School Of Medicine At Mount Sinai · R24 · FY2025 · AI
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
$834,248Bing Chen · Boston Children'S Hospital · R01 · FY2021 · AI
Prenatal to Preschool: The Impact of the Pandemic on Mothers and children, with a focus on syndemic effects on Black families
$834,125Wanjiku Felicia Mbugua Njoroge · Children'S Hosp Of Philadelphia · R01 · FY2022 · MH
SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR)
$833,123Linda Y. Kim · Cedars-Sinai Medical Center · R01 · FY2024 · MH
A micronized electrostatic precipitator for next-generation respiratory protection against pathogenic aerosols
$832,868Julian Henley · Henley Ion, Llc · R44 · FY2024 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$832,784Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
Administrative Core
$832,784Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
$832,650Lanying Du · New York Blood Center · R01 · FY2020 · AI
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$831,392John Hsu · Massachusetts General Hospital · U01 · FY2022 · AG
Balancing epithelial cell resistance and resilience to respiratory viral infections
$831,352Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2025 · HL
Dissecting the drivers of persistent SARS-CoV-2 infections
$831,341Viviana A Simon · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Explore a key nucleotide synthesis enzyme to develop a broad-spectrum antiviral therapy.
$831,235Pinghui Feng · University Of Southern California · R01 · FY2025 · AI
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
$830,331Steven B Abramson · New York University School Of Medicine · R01 · FY2024 · HL
Thermostabilized Subunit Glycoprotein Vaccine Platform: Immune Characterization of an Emulsified Adjuvant with SARS-CoV-2 Spike Protein and EBOV GP
$829,746Oreola Donini · Soligenix, Inc. · R44 · FY2022 · AI